表紙:非侵襲性脳刺激システムの世界市場 - 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
市場調査レポート
商品コード
1166022

非侵襲性脳刺激システムの世界市場 - 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)

Non-invasive Brain Stimulation System Market (Product Type: Transcranial Magnetic Stimulation [TMS] System and Transcranial Current Stimulation [TCS] System) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 180 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
非侵襲性脳刺激システムの世界市場 - 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
出版日: 2022年10月20日
発行: Transparency Market Research
ページ情報: 英文 180 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の非侵襲性脳刺激システム市場について調査分析し、市場動向、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の非侵襲性脳刺激システム市場の予測
  • 世界の非侵襲性脳刺激システム市場の見通し

第5章 市場の見通し

  • 主な業界イベント(合併、買収、パートナーシップ、提携など)
  • 主な製品/ブランドの分析
  • 疾患の疫学
  • COVID-19パンデミックの業界に対する影響(バリューチェーンと短期・中期・長期の影響)

第6章 世界の非侵襲性脳刺激システム市場の分析と予測:製品タイプ別

  • イントロダクション
  • 世界の非侵襲性脳刺激システムの市場金額シェアと魅力分析:製品タイプ別
  • 世界の非侵襲性脳刺激システム市場の予測:製品タイプ別
    • 経頭蓋磁気刺激(TMS)システム
    • 経頭蓋電流刺激(TCS)システム
  • 世界の非侵襲性脳刺激システム市場の分析:製品タイプ別

第7章 世界の非侵襲性脳刺激システム市場の分析と予測:用途別

  • イントロダクション
  • 世界の非侵襲性脳刺激システムの市場金額シェアと魅力分析:用途別
  • 世界の非侵襲性脳刺激システム市場の予測:用途別
    • 抑うつ
    • てんかん
    • パーキンソン病
    • 慢性疼痛
    • その他
  • 世界の非侵襲性脳刺激システム市場の分析:用途別

第8章 世界の非侵襲性脳刺激システム市場の分析と予測:エンドユーザー別

  • イントロダクション
  • 世界の非侵襲性脳刺激システムの市場金額シェアと魅力分析:エンドユーザー別
  • 世界の非侵襲性脳刺激システム市場の予測:エンドユーザー別
    • 病院
    • 外来手術センター
    • 専門診療所
    • その他
  • 世界の非侵襲性脳刺激システム市場の分析:エンドユーザー別

第9章 世界の非侵襲性脳刺激システム市場の分析:地域別

  • 世界の非侵襲性脳刺激システム市場の分析:地域別
  • 世界の非侵襲性脳刺激システムの市場金額シェアと魅力分析:地域別
  • 世界の非侵襲性脳刺激システム市場の予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第10章 北米の非侵襲性脳刺激システム市場の分析

  • 北米の非侵襲性脳刺激システム市場の概要
  • 北米の非侵襲性脳刺激システムの市場金額シェアと魅力分析:国別
  • 北米の非侵襲性脳刺激システム市場の予測:国別
    • 米国
    • カナダ
  • 北米の非侵襲性脳刺激システムの市場金額シェアと魅力分析:製品タイプ別
  • 北米の非侵襲性脳刺激システム市場の予測:製品タイプ別
  • 北米の非侵襲性脳刺激システムの市場金額シェアと魅力分析:用途別
  • 北米の非侵襲性脳刺激システム市場の予測:用途別
  • 北米の非侵襲性脳刺激システムの市場金額シェアと魅力分析:エンドユーザー別
  • 北米の非侵襲性脳刺激システム市場の予測:エンドユーザー別

第11章 欧州の非侵襲性脳刺激システム市場の分析

第12章 アジア太平洋の非侵襲性脳刺激システム市場の分析

第13章 ラテンアメリカの非侵襲性脳刺激システム市場の分析

第14章 中東・アフリカの非侵襲性脳刺激システム市場の分析

第15章 競合情勢

  • 市場企業 - 競合マトリックス:階層・企業規模別
  • 企業プロファイル
    • Brainbox Ltd.
    • BrainsWay
    • eNeura, Inc.
    • Flow Neuroscience
    • Magnus Medical, Inc.
    • Magstim
    • MagVenture
    • NeoSync, Inc. (Wave Neuroscience, Inc.)
    • NeuraLace
    • neurocare group AG
    • NeuroMetrix
    • Neuronetics
    • Soterix Medical, Inc.
図表

List of Tables

  • Table 01: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Brainbox Ltd. Business Overview
  • Table 26: BrainsWay Business Overview
  • Table 27: eNeura Inc. Overview
  • Table 28: Flow Neuroscience Business Overview
  • Table 29: Magnus Medical, Inc. Business Overview
  • Table 30: Magstim Business Overview
  • Table 31: MagVenture Business Overview
  • Table 32: NeoSync, Inc. (Wave Neuroscience, Inc.) Business Overview
  • Table 33: NeuraLace Business Overview
  • Table 34: neurocare group AG Business Overview
  • Table 35: NeuroMetrix Business Overview
  • Table 36: Neuronetics Business Overview
  • Table 37: Soterix Medical, Inc.Business Overview

List of Figures

  • Figure 01: Market Share, by Product Type
  • Figure 02: Market Share, by Application
  • Figure 03: Market Share, by Region
  • Figure 04: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 05: Global Non-invasive Brain Stimulation System Market Value Share, by Product Type, 2021
  • Figure 06: Global Non-invasive Brain Stimulation System Market Value Share, by End-user, 2021
  • Figure 07: Global Non-invasive Brain Stimulation System Market Value Share, by Application, 2021
  • Figure 08: Global Non-invasive Brain Stimulation System Market Value Share, by Region, 2021
  • Figure 09: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 10: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 11: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Transcranial Magnetic Stimulation (TMS) System, 2017-2031
  • Figure 12: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Transcranial Current Stimulation (TCS) System, 2017-2031
  • Figure 13: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 14: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 15: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Depression, 2017-2031
  • Figure 16: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Epilepsy, 2017-2031
  • Figure 17: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Parkinson's Disease, 2017-2031
  • Figure 18: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Chronic Pain, 2017-2031
  • Figure 19: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 20: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 21: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 22: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 23: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017-2031
  • Figure 24: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Specialty Clinic, 2017-2031
  • Figure 25: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 26: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 27: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 28: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 29: North America Non-invasive Brain Stimulation System Market Value Share (%), by Country, 2021 and 2031
  • Figure 30: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 31: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 32: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 33: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 34: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 35: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 36: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 37: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 38: Europe Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 39: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 40: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 41: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 42: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 43: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 44: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 45: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 46: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 47: Asia Pacific Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 48: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 49: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 50: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 51: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 52: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 53: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 54: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 56: Latin America Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 57: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 58: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 59: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 60: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 61: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 62: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 63: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 64: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 65: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 66: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 67: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 68: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 69: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 70: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 71: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 72: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022-2031
目次
Product Code: TMRGL80830

TMR's report on the global non-invasive brain stimulation system market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global non-invasive brain stimulation system market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive brain stimulation system market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the non-invasive brain stimulation system market.

The report delves into the competitive landscape of the global non-invasive brain stimulation system market. Key players operating in the global non-invasive brain stimulation system market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global non-invasive brain stimulation system market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunity
  • 4.3. Global Non-invasive Brain Stimulation System Market Forecast
  • 4.4. Global Non-invasive Brain Stimulation System Market Outlook

5. Market Outlook

  • 5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
  • 5.2. Key product/Brand Analysis
  • 5.3. Diseases Epidemiology
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Product Type

  • 6.1. Introduction
  • 6.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
  • 6.3. Global Non-invasive Brain Stimulation System Market Forecast, by Product Type
    • 6.3.1. Transcranial Magnetic Stimulation (TMS) System
    • 6.3.2. Transcranial Current Stimulation (TCS) System
  • 6.4. Global Non-invasive Brain Stimulation System Market Analysis, by Product Type

7. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Application

  • 7.1. Introduction
  • 7.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
  • 7.3. Global Non-invasive Brain Stimulation System Market Forecast, by Application
    • 7.3.1. Depression
    • 7.3.2. Epilepsy
    • 7.3.3. Parkinson's Disease
    • 7.3.4. Chronic Pain
    • 7.3.5. Others
  • 7.4. Global Non-invasive Brain Stimulation System Market Analysis, by Application

8. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by End-user

  • 8.1. Introduction
  • 8.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
  • 8.3. Global Non-invasive Brain Stimulation System Market Forecast, by End-user
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Specialty Clinics
    • 8.3.4. Others
  • 8.4. Global Non-invasive Brain Stimulation System Market Analysis, by End-user

9. Global Non-invasive Brain Stimulation System Market Analysis, by Region

  • 9.1. Global Non-invasive Brain Stimulation System Market Analysis, by Region
  • 9.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Non-invasive Brain Stimulation System Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Non-invasive Brain Stimulation System Market Analysis

  • 10.1. North America Non-invasive Brain Stimulation System Market Overview
  • 10.2. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
  • 10.3. North America Non-invasive Brain Stimulation System Market Forecast, by Country
    • 10.3.1. U.S.
    • 10.3.2. Canada
  • 10.4. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
  • 10.5. North America Non-invasive Brain Stimulation System Market Forecast, by Product Type
    • 10.5.1. Transcranial Magnetic Stimulation (TMS) System
    • 10.5.2. Transcranial Current Stimulation (TCS) System
  • 10.6. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
  • 10.7. North America Non-invasive Brain Stimulation System Market Forecast, by Application
    • 10.7.1. Depression
    • 10.7.2. Epilepsy
    • 10.7.3. Parkinson's Disease
    • 10.7.4. Chronic Pain
    • 10.7.5. Others
  • 10.8. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
  • 10.9. North America Non-invasive Brain Stimulation System Market Forecast, by End-user
    • 10.9.1. Hospitals
    • 10.9.2. Ambulatory Surgical Centers
    • 10.9.3. Specialty Clinics
    • 10.9.4. Others

11. Europe Non-invasive Brain Stimulation System Market Analysis

  • 11.1. Europe Non-invasive Brain Stimulation System Market Overview
  • 11.2. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.3. Europe Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
    • 11.3.1. Germany
    • 11.3.2. U.K.
    • 11.3.3. France
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Rest of Europe
  • 11.4. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
  • 11.5. Europe Non-invasive Brain Stimulation System Market Forecast, by Product Type
    • 11.5.1. Transcranial Magnetic Stimulation (TMS) System
    • 11.5.2. Transcranial Current Stimulation (TCS) System
  • 11.6. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
  • 11.7. Europe Non-invasive Brain Stimulation System Market Forecast, by Application
    • 11.7.1. Depression
    • 11.7.2. Epilepsy
    • 11.7.3. Parkinson's Disease
    • 11.7.4. Chronic Pain
    • 11.7.5. Others
  • 11.8. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
  • 11.9. Europe Non-invasive Brain Stimulation System Market Forecast, by End-user
    • 11.9.1. Hospitals
    • 11.9.2. Ambulatory Surgical Centers
    • 11.9.3. Specialty Clinics
    • 11.9.4. Others

12. Asia Pacific Non-invasive Brain Stimulation System Market Analysis

  • 12.1. Asia Pacific Non-invasive Brain Stimulation System Market Overview
  • 12.2. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.3. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
    • 12.3.1. China
    • 12.3.2. India
    • 12.3.3. Japan
    • 12.3.4. Australia & New Zealand
    • 12.3.5. Rest of Asia Pacific
  • 12.4. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
  • 12.5. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Product Type
    • 12.5.1. Transcranial Magnetic Stimulation (TMS) System
    • 12.5.2. Transcranial Current Stimulation (TCS) System
  • 12.6. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
  • 12.7. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Application
    • 12.7.1. Depression
    • 12.7.2. Epilepsy
    • 12.7.3. Parkinson's Disease
    • 12.7.4. Chronic Pain
    • 12.7.5. Others
  • 12.8. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
  • 12.9. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by End-user
    • 12.9.1. Hospitals
    • 12.9.2. Ambulatory Surgical Centers
    • 12.9.3. Specialty Clinics
    • 12.9.4. Others

13. Latin America Non-invasive Brain Stimulation System Market Analysis

  • 13.1. Latin America Non-invasive Brain Stimulation System Market Overview
  • 13.2. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.3. Latin America Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
    • 13.3.1. Brazil
    • 13.3.2. Mexico
    • 13.3.3. Rest of Latin America
  • 13.4. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
  • 13.5. Latin America Non-invasive Brain Stimulation System Market Forecast, by Product Type
    • 13.5.1. Transcranial Magnetic Stimulation (TMS) System
    • 13.5.2. Transcranial Current Stimulation (TCS) System
  • 13.6. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
  • 13.7. Latin America Non-invasive Brain Stimulation System Market Forecast, by Application
    • 13.7.1. Depression
    • 13.7.2. Epilepsy
    • 13.7.3. Parkinson's Disease
    • 13.7.4. Chronic Pain
    • 13.7.5. Others
  • 13.8. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
  • 13.9. Latin America Non-invasive Brain Stimulation System Market Forecast, by End-user
    • 13.9.1. Hospitals
    • 13.9.2. Ambulatory Surgical Centers
    • 13.9.3. Specialty Clinics
    • 13.9.4. Others

14. Middle East & Africa Non-invasive Brain Stimulation System Market Analysis

  • 14.1. Middle East & Africa Non-invasive Brain Stimulation System Market Overview
  • 14.2. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
  • 14.3. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
    • 14.3.1. GCC Countries
    • 14.3.2. South Africa
    • 14.3.3. Rest of Middle East & Africa
  • 14.4. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
  • 14.5. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Product Type
    • 14.5.1. Transcranial Magnetic Stimulation (TMS) System
    • 14.5.2. Transcranial Current Stimulation (TCS) System
  • 14.6. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
  • 14.7. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Application
    • 14.7.1. Depression
    • 14.7.2. Epilepsy
    • 14.7.3. Parkinson's Disease
    • 14.7.4. Chronic Pain
    • 14.7.5. Others
  • 14.8. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
  • 14.9. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by End-user
    • 14.9.1. Hospitals
    • 14.9.2. Ambulatory Surgical Centers
    • 14.9.3. Specialty Clinics
    • 14.9.4. Others

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Brainbox Ltd.
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. Financial Overview
      • 15.2.1.4. Strategic Overview
      • 15.2.1.5. SWOT Analysis
    • 15.2.2. BrainsWay
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. Strategic Overview
      • 15.2.2.4. SWOT Analysis
    • 15.2.3. eNeura, Inc.
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. Strategic Overview
      • 15.2.3.4. SWOT Analysis
    • 15.2.4. Flow Neuroscience
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. Strategic Overview
      • 15.2.4.4. SWOT Analysis
    • 15.2.5. Magnus Medical, Inc.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. Strategic Overview
      • 15.2.5.4. SWOT Analysis
    • 15.2.6. Magstim
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. Strategic Overview
      • 15.2.6.4. SWOT Analysis
    • 15.2.7. MagVenture
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. Strategic Overview
      • 15.2.7.4. SWOT Analysis
    • 15.2.8. NeoSync, Inc. (Wave Neuroscience, Inc.)
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. Strategic Overview
      • 15.2.8.4. SWOT Analysis
    • 15.2.9. NeuraLace
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. Strategic Overview
      • 15.2.9.4. SWOT Analysis
    • 15.2.10. neurocare group AG
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Product Portfolio
      • 15.2.10.3. Strategic Overview
      • 15.2.10.4. SWOT Analysis
    • 15.2.11. NeuroMetrix
      • 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.11.2. Product Portfolio
      • 15.2.11.3. Strategic Overview
      • 15.2.11.4. SWOT Analysis
    • 15.2.12. Neuronetics
      • 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.12.2. Product Portfolio
      • 15.2.12.3. Strategic Overview
      • 15.2.12.4. SWOT Analysis
    • 15.2.13. Soterix Medical, Inc.
      • 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.13.2. Product Portfolio
      • 15.2.13.3. Strategic Overview